Minireview: on the Structure and Gating Mechanism of the Mitochondrial Channel, VDAC
Overview
Biology
Endocrinology
Authors
Affiliations
There is considerable evidence that the voltage-gated mitochondrial channel VDAC forms a beta-barrel pore. Inferences about the number and tilt of beta-strands can be drawn from comparisons with bacterial beta-barrel pores whose structures have been determined by x-ray crystallography. A structural model for VDAC is proposed (based on sequence analysis and electron crystallography) in which the open state is like that of bacterial porins with several important differences. Because VDAC does not occur as close-packed trimers, there are probably fewer interpore contacts than in the bacterial porins. VDAC also appears to lack a large, fixed intraluminal segment and may not have as extensive a region of uniformly 35 degrees -tilted beta-strands as do the bacterial porins. These structural differences would be expected to render VDAC's beta-barrel less stable than its bacterial counterparts, making major conformational changes like those associated with gating more energetically feasible. A possible gating mechanism is suggested in which movement of the N-terminal alpha-helix out of the lumen wall triggers larger-scale structural changes.
Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1.
Arif T, Shteinfer-Kuzmine A, Shoshan-Barmatz V Biomolecules. 2024; 14(10).
PMID: 39456237 PMC: 11506819. DOI: 10.3390/biom14101304.
Reina S, Checchetto V Front Physiol. 2022; 12:784867.
PMID: 35082690 PMC: 8784847. DOI: 10.3389/fphys.2021.784867.
Paschon V, Morena B, Correia F, Beltrame G, Santos G, Cristante A Sci Rep. 2019; 9(1):14063.
PMID: 31575916 PMC: 6773716. DOI: 10.1038/s41598-019-50506-4.
Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
Shoshan-Barmatz V, Krelin Y, Shteinfer-Kuzmine A, Arif T Front Oncol. 2017; 7:154.
PMID: 28824871 PMC: 5534932. DOI: 10.3389/fonc.2017.00154.
Anion Channels of Mitochondria.
Ponnalagu D, Singh H Handb Exp Pharmacol. 2016; 240:71-101.
PMID: 27783269 PMC: 5855116. DOI: 10.1007/164_2016_39.